More Accurate Probiotic Quality Control: A Strain-Specific PMA-qPCR Method for IDCC 3701
Accurate quantification of viable probiotic cells is essential for product quality control, label compliance, and formulation development. This becomes particularly challenging in multi-strain probiotic products, where individual strains must be selectively identified and quantified within a complex mixture.
Conventional plate counting remains a widely used reference method for probiotic enumeration. However, it is time-consuming, depends on the culturability of bacterial cells, and can be difficult to apply when multiple strains are present in the same formulation. Meanwhile, conventional quantitative PCR (qPCR) offers rapid and strain-specific detection but cannot inherently distinguish DNA originating from viable cells from that of dead cells.
To address these challenges, researchers at ILDONG Bioscience developed and validated a strain-specific propidium monoazide-qPCR (PMA-qPCR) assay for Limosilactobacillus reuteri IDCC 3701 (RE). Published in the Journal of Microbiological Methods in 2026, the study introduced a matrix-matched calibration strategy using freeze-dried probiotic powder to improve quantitative accuracy in commercial-style multi-strain formulations.
1. Why Accurate Strain-Specific Viability Measurement Matters
Probiotic products often contain multiple bacterial strains, each contributing to the intended product formulation. Verifying the viable count of each individual strain is therefore important for maintaining consistent product quality and ensuring that declared specifications are supported by reliable analytical data.
Three commonly used approaches have different analytical characteristics:
Plate counting: Measures colony-forming units (CFU) and primarily detects cells capable of forming colonies under the selected culture conditions. However, it is labor-intensive and may not recover viable but non-culturable (VBNC) cells.
Conventional qPCR: Provides rapid and strain-specific DNA detection, but detects genetic material from both viable and non-viable cells.
PMA-qPCR: Combines qPCR with a DNA-intercalating dye to suppress amplification of DNA from membrane-compromised cells, enabling preferential quantification of membrane-intact bacterial populations.
PMA-qPCR therefore offers an additional analytical perspective by addressing one of the major limitations of conventional qPCR: the potential overestimation of viable cell counts due to residual DNA from dead bacteria.
2. Study Objective and Experimental Design
The researchers developed a PMA-qPCR assay specifically targeting L. reuteri IDCC 3701 (RE), an industrial probiotic strain used in multi-strain formulations.
The study focused on four main objectives:
Develop strain-specific primers using comparative genomic analysis.
Evaluate the ability of PMAxx™ to suppress DNA amplification from dead cells.
Validate assay linearity and detection performance in pure and mixed cultures.
Evaluate quantitative accuracy in single-strain and four-strain freeze-dried probiotic powders.
Bacterial strains used
Four ILDONG Bioscience strains were included in the study:
Strain | Abbreviation | Role in the study |
Limosilactobacillus reuteri IDCC 3701 | RE | Target strain |
Lacticaseibacillus rhamnosus IDCC 3201 | RH | Background strain |
Lactobacillus acidophilus IDCC 2201 | AC | Background strain |
Limosilactobacillus fermentum IDCC 3901 | FE | Background strain |
The assay was designed to selectively quantify RE, while RH, AC, and FE were used to evaluate primer specificity and analytical performance in a multi-strain environment.
PMA-qPCR analytical procedure
The analytical workflow involved the following steps:
PMAxx treatment: Samples were treated with 50 μM PMAxx and incubated in the dark for 5 minutes.
Photoactivation: Samples were exposed to blue LED light (465–475 nm) for 15 minutes.
DNA extraction: Genomic DNA was extracted after PMAxx treatment.
qPCR analysis: RE-specific primers were used for quantitative real-time PCR.
Calibration: Standard curves were generated using known viable counts from either culture broth or freeze-dried RE powder.
A key feature of this study was the use of freeze-dried powder-based calibration to account for potential differences between liquid culture samples and actual commercial probiotic powder matrices.
3. Key Research Findings
Finding 1. High Strain Specificity of the RE-Specific Primers
The researchers used comparative genomic analysis to identify a unique genomic region in IDCC 3701 that was not detected in the other tested in-house strains.
The designed primers were evaluated using DNA extracted from RE, RH, AC, and FE.
The results demonstrated:
A single, distinct melting peak was observed with RE DNA.
No detectable melting peaks were observed with RH, AC, or FE DNA.
No apparent cross-reactivity was observed among the three non-target strains.
These findings support the specificity of the designed primer pair for identifying IDCC 3701 within the tested strain panel.
This is particularly relevant to multi-strain probiotic formulations, where conventional enumeration methods may struggle to distinguish individual strains.
Finding 2. PMAxx Suppressed 99.985% of Dead-Cell DNA Amplification
One of the most important steps in PMA-qPCR is differentiating DNA from membrane-intact cells and DNA from membrane-compromised cells.
The researchers evaluated four conditions using live and heat-killed RE cells, with and without PMAxx treatment.
The reported qPCR results were:
Experimental condition | Ct value |
Live RE, without PMAxx | 12.892 |
Heat-killed RE, without PMAxx | 14.514 |
Live RE, with PMAxx | 14.602 |
Heat-killed RE, with PMAxx | 27.187 |
Without PMAxx treatment, conventional qPCR generated similar Ct values for live and heat-killed cells, demonstrating its inability to reliably distinguish between the two populations.
Following PMAxx treatment, the Ct value of heat-killed RE increased substantially.
The difference corresponded to approximately 99.985% suppression of dead-cell DNA amplification.
Importantly, PMAxx treatment also caused a smaller Ct shift of 1.710 in live RE samples. This indicates that the treatment can partially suppress signals from cells with compromised or damaged membranes, even within a nominally viable culture.
Overall, the results demonstrate that PMAxx can substantially reduce the contribution of dead-cell DNA to qPCR measurements while largely preserving the signal from membrane-intact cells.
Finding 3. Reliable Quantification Across a Wide Concentration Range
The assay was evaluated using serially diluted RE cultures to determine its quantitative performance.
A strong linear relationship was observed between qPCR cycle threshold (Ct) values and logarithmic viable cell concentrations.
Performance parameter | Result |
Quantification range in pure culture | 10⁴–10⁹ CFU/mL |
Coefficient of determination (R²) | 0.9951 |
Standard deviation of Ct values | ≤0.5 |
Limit of detection (LoD) | Approximately 10⁴ CFU/mL |
Limit of quantification (LoQ) | Approximately 10⁴ CFU/mL |
The assay was also evaluated in mixed cultures containing RE, RH, AC, and FE.
Even in the presence of the three additional strains, the assay maintained a comparable detection limit of approximately 10⁴ CFU/mL, with an R² value of 0.9966.
These findings indicate that the RE-specific PMA-qPCR assay maintained strong linearity and target specificity in both pure and mixed-culture conditions.
Finding 4. Powder-Based Calibration Improved Quantification Accuracy
A particularly important contribution of this study was the evaluation of different calibration strategies.
Many molecular enumeration methods use broth-derived standard curves. However, commercial probiotic products are often manufactured as freeze-dried powders containing protective excipients and other formulation components.
Differences in sample composition, physical state, cell aggregation, and DNA extraction efficiency may influence analytical results.
To address this issue, the researchers compared two calibration approaches:
Broth-based calibration: Standard curves generated from RE culture broth.
Powder-based calibration: Standard curves generated directly from freeze-dried RE powder with known viable counts.
The results showed a clear difference in quantitative accuracy.
Calibration method | Mean deviation from plate-count results |
Broth-based standard curve | −1.163 log CFU/g |
Powder-based standard curve | −0.537 log CFU/g |
The absolute mean deviation was reduced by approximately 54% when powder-based calibration was used.
Bland–Altman analysis also supported this improvement:
Broth-based calibration: Mean bias of −1.163 log CFU/g, with 95% limits of agreement from −1.669 to −0.657 log CFU/g.
Powder-based calibration: Mean bias of −0.537 log CFU/g, with 95% limits of agreement from −1.167 to +0.093 log CFU/g.
The powder-based standard curve produced estimates closer to the plate-count results in the three evaluated single-strain powder samples.
This finding highlights the importance of considering the actual product matrix when developing quantitative analytical methods for probiotic ingredients.
Finding 5. Application to Four-Strain Probiotic Powders
The researchers further evaluated the assay using four-strain freeze-dried probiotic powders containing RE, RH, AC, and FE.
Using the powder-based standard curve, the viable RE counts were estimated in four independently prepared mixed-powder samples.
Sample | Input value (log CFU/g) | PMA-qPCR estimate (log CFU/g) |
1 | 8.875 | 7.972 |
2 | 8.875 | 8.516 |
3 | 8.875 | 8.152 |
4 | 8.875 | 8.520 |
The mean deviation between the estimated and input values was 0.585 log CFU/g.
All four samples fell within the 95% limits of agreement reported in the Bland–Altman analysis.
The results demonstrate the practical applicability of the assay to strain-specific quantification in complex multi-strain probiotic powders.
However, the estimated RE counts were lower than the theoretical input values. This difference should be considered when interpreting the method's quantitative performance in mixed formulations.
It is also important to note that full quantitative validation in this study was performed for RE. The other three strains were included as background strains to challenge assay specificity, rather than as independently validated quantitative targets.
4. Why Matrix-Matched Calibration Matters for Probiotic Quality Control
The study provides an important insight into the development of reliable analytical methods for probiotic products: the accuracy of a quantitative assay depends not only on the detection technology but also on how closely the calibration standards represent the actual sample matrix.
Freeze-dried probiotic powders differ from liquid cultures in several ways, including:
Presence of protective excipients and carrier materials
Differences in cell aggregation and physical distribution
Potential effects on DNA extraction efficiency
Differences in PMAxx accessibility and treatment conditions
Using a calibration standard prepared from the same type of powder matrix can help account for these variables and reduce systematic measurement bias.
For probiotic manufacturers, this approach may support more reliable analytical workflows for:
Strain-specific viable count verification
Multi-strain formulation quality control
Product development and formulation optimization
Stability and shelf-life monitoring
Verification of declared viable cell specifications
The method also provides a framework for developing similar strain-specific assays for other industrial probiotic strains, although each new strain and formulation would require its own primer design and validation.
5. Understanding the Method's Scope and Limitations
Although PMA-qPCR offers clear advantages for strain-specific viability-oriented analysis, its results should be interpreted according to the biological characteristics measured by the method.
PMAxx primarily differentiates cells based on membrane integrity. It does not directly measure metabolic activity or the ability of a cell to reproduce.
Consequently, membrane-intact cells may include viable but non-culturable populations that are not detected by conventional plate counting. Conversely, cells with compromised membranes may be excluded from the PMA-qPCR signal.
The researchers also noted several areas for further development:
Additional validation across different strains and powder formulations
Evaluation using complementary viability techniques, such as flow cytometry
Further optimization of DNA extraction and PMA treatment
Improved workflow automation for higher-throughput quality control
Therefore, PMA-qPCR should be considered a complementary analytical tool rather than a universal replacement for conventional plate counting.
Conclusion
The 2026 study by ILDONG Bioscience researchers demonstrates a practical approach to improving strain-specific viability assessment in multi-strain probiotic powders.
By combining comparative genomics-based primer design, PMAxx treatment, and powder-matched calibration, the researchers developed a PMA-qPCR assay capable of selectively quantifying Limosilactobacillus reuteri IDCC 3701.
The key findings include:
99.985% suppression of dead-cell DNA amplification following PMAxx treatment.
A quantitative range of 10⁴–10⁹ CFU/mL in pure cultures.
High linearity in pure and mixed cultures, with R² values of 0.9951 and 0.9966, respectively.
Approximately 54% lower absolute mean deviation when powder-based calibration was used instead of broth-based calibration.
Successful application to four-strain freeze-dried probiotic powders.
For the probiotic industry, accurate strain-specific quantification is an essential component of product quality and consistency.
At ILDONG Bioscience, we continue to advance probiotic analytical technologies and quality control approaches to support reliable strain identification, viable cell enumeration, and the development of high-quality multi-strain probiotic products.
Publication Reference
Lee, J., & Moon, J. S. (2026). Development and validation of a propidium monoazide-qPCR assay with matrix-matched calibration for selective quantification of viable Limosilactobacillus reuteri in multi-strain probiotic powders. Journal of Microbiological Methods, 244, 107467.
